April 16 (Reuters) - Merck & Co (MRK.N), opens new tab said on Sunday it will buy Prometheus Biosciences Inc (RXDX.O), opens new tab for about $10.8 billion, picking up a promising experimental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback